$4.21
2.09% yesterday
Nasdaq, Aug 01, 10:00 pm CET
ISIN
US0390142042
Symbol
RKDA

Arcadia Biosciences, Inc. Stock price

$4.21
-0.22 4.97% 1M
-0.79 15.80% 6M
-1.71 28.89% YTD
+1.28 43.69% 1Y
-28.66 87.19% 3Y
-144.44 97.17% 5Y
-3,488.30 99.88% 10Y
-5,829.96 99.93% 20Y
Nasdaq, Closing price Fri, Aug 01 2025
-0.09 2.09%
ISIN
US0390142042
Symbol
RKDA
Industry

Key metrics

Basic
Market capitalization
$5.9m
Enterprise Value
$2.7m
Net debt
positive
Cash
$3.2m
Shares outstanding
1.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.1 | 0.9
EV/Sales
0.5 | 0.4
EV/FCF
negative
P/B
0.7
Financial Health
Equity Ratio
46.0%
Return on Equity
-113.1%
ROCE
-56.9%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$5.3m | $6.5m
EBITDA
$-6.1m | $-2.6m
EBIT
$-6.1m | $-2.6m
Net Income
$-2.0m | $-80.0k
Free Cash Flow
$-8.0m
Growth (TTM | estimate)
Revenue
9.4% | 29.3%
EBITDA
43.2% | 65.1%
EBIT
43.9% | 65.4%
Net Income
71.3% | 98.9%
Free Cash Flow
46.8%
Margin (TTM | estimate)
Gross
42.6%
EBITDA
-115.0% | -39.3%
EBIT
-116.5%
Net
-38.3% | -1.3%
Free Cash Flow
-152.3%
More
EPS
$-1.5
FCF per Share
$-5.8
Short interest
1.6%
Employees
9
Rev per Employee
$560.0k
Show more

Is Arcadia Biosciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,028 stocks worldwide.

Arcadia Biosciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Arcadia Biosciences, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Arcadia Biosciences, Inc. forecast:

Buy
86%
Hold
14%

Financial data from Arcadia Biosciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
5.26 5.26
9% 9%
100%
- Direct Costs 3.02 3.02
20% 20%
57%
2.24 2.24
2% 2%
43%
- Selling and Administrative Expenses 9.32 9.32
23% 23%
177%
- Research and Development Expense 0.05 0.05
95% 95%
1%
-6.05 -6.05
43% 43%
-115%
- Depreciation and Amortization 0.08 0.08
70% 70%
2%
EBIT (Operating Income) EBIT -6.13 -6.13
44% 44%
-116%
Net Profit -2.02 -2.02
71% 71%
-38%

In millions USD.

Don't miss a Thing! We will send you all news about Arcadia Biosciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Arcadia Biosciences, Inc. Stock News

Neutral
Seeking Alpha
3 months ago
Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q1 2025 Earnings Conference Call May 8, 2025 2:00 PM ET Company Participants Mark Kawakami - Chief Financial Officer T.J. Schaefer - President and Chief Executive Officer Conference Call Participants Ben Klee - Lake Street Operator Hello, and welcome to Arcadia Biosciences First Quarter 2025 Financial Results and Business Highlights Conference Call.
Neutral
GlobeNewsWire
3 months ago
-- Revenues increase 22% year over year driven by 90% growth in Zola ® -- -- Arcadia sells patents for $750K and eliminates $1M in liabilities -- -- Roosevelt agreement amended to provide greater certainty regarding exchange ratio -- DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc .® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness product...
Neutral
GlobeNewsWire
3 months ago
Arcadia Biosciences, Inc.® (Nasdaq: RKDA) will release its financial and business results for the first quarter of 2025 on May 8, 2025 at 2:00 p.m. ET.
More Arcadia Biosciences, Inc. News

Company Profile

Arcadia Biosciences, Inc. is an agricultural biotechnology company which engages in the development of agricultural products for the improvement of the environment and human health. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. The company's portfolio of agricultural productivity traits includes Nitrogen Use Efficiency, Water Use Efficiency, Drought Tolerance, Salinity Tolerance and Herbicide Tolerance. It has presence in the United States, Africa, India, the United Arab Emirates, Belgium, France and Canada. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Davis, CA.

Head office United States
CEO Thomas Schaefer
Employees 9
Founded 2002
Website arcadiabio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today